These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1780525)
21. [The current situation of therapy in hyperlipemias]. Vallina Alvarez E; Arribas Castrillo JM; Suárez García E An Med Interna; 1990 Jul; 7(7):370-4. PubMed ID: 2103252 [No Abstract] [Full Text] [Related]
24. [Blood coagulation and fibrinolysis systems in patients with hypertriglyceridemia treated with 1,5-dicoffeechinic acid]. Borodin M; Jurek D; Gregorczyk J; Wójcicki J; Olejak B; Pieczul-Mróz J Przegl Lek; 1982 Sep; 39(8):525-32. PubMed ID: 6897121 [No Abstract] [Full Text] [Related]
25. [Treatment of primary hyperlipidemia with 5-methylpyrazinecarboxylic acid (acipimox)]. Quintão EC; de Castilho LN Arq Bras Cardiol; 1985 Jan; 44(1):37-40. PubMed ID: 4062591 [No Abstract] [Full Text] [Related]
26. [Effect of glucagon on plasma lipids in normal and hyperlipemic subjects]. Jover E; Berdugo A; Rodríguez F; Velasco R Rev Clin Esp; 1985 Apr; 176(6):281-5. PubMed ID: 4001485 [No Abstract] [Full Text] [Related]
27. Drug therapy for hyperlipidemia. Franklin FA; Margolis S Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855 [No Abstract] [Full Text] [Related]
28. [What should be done for relatively young hyperlipidemic patients following myocardial infarction?]. Faergeman O Ugeskr Laeger; 1983 Mar; 145(13):976-7. PubMed ID: 6857806 [No Abstract] [Full Text] [Related]
29. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050 [No Abstract] [Full Text] [Related]
31. [The clinical pharmacology and efficacy of statins]. Sidorenko BA; Preobrazhenskiĭ DV; Sopoleva IuV Ter Arkh; 1996; 68(9):80-4. PubMed ID: 9005624 [No Abstract] [Full Text] [Related]
32. Drug therapy of the hyperlipidemias. Armstrong ML Iowa Med; 1985 Jan; 75(1):26-30. PubMed ID: 3967963 [No Abstract] [Full Text] [Related]
33. [Treatment of dyslipidemia]. Cybulska B Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():11-2. PubMed ID: 12621774 [No Abstract] [Full Text] [Related]
34. Apolipoprotein B metabolism in dyslipidaemia and the effect of drugs. Packard CJ Diabetes Nutr Metab; 1999 Oct; 12(5):311-5. PubMed ID: 10741344 [No Abstract] [Full Text] [Related]
35. [Controversies and advances in the treatment of hyperlipidemias]. Reza-Albarrán A; Aguilar-Salinas CA Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005 [No Abstract] [Full Text] [Related]
37. [Novel perspective approaches to the therapy of dyslipidaemias]. Adameová A; Kuzelová M; Svec P Ceska Slov Farm; 2005 May; 54(3):103-8. PubMed ID: 15945455 [TBL] [Abstract][Full Text] [Related]
39. Dyslipidemia and coronary heart disease: management issues from Indian perspective. Gambhir DS; Gambhir JK; Sudha R Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772 [No Abstract] [Full Text] [Related]
40. Clinical inquiries. Should we identify and treat hyperlipidemia in the advanced elderly? Shah K; Rogers J; Britigan D; Levy C J Fam Pract; 2006 Apr; 55(4):356-7. PubMed ID: 16608678 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]